Harvard Men's Health Watch

Prostate-specific antigen: A new(ish) study

The controversy over PSA testing continues, with a study from Sweden suggesting that testing does reduce the risk of death from prostate cancer, but the issue is by no means resolved.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In